Immix Biopharma, Inc.IMMXNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+50.4%
5Y CAGR+131.6%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+50.4%/yr
Annual compound
5Y CAGR
+131.6%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
66.6x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $13.70M | +20.3% |
| 2024 | $11.38M | +53.7% |
| 2023 | $7.41M | +84.1% |
| 2022 | $4.02M | +228.3% |
| 2021 | $1.23M | +495.8% |
| 2020 | $205703.00 | -20.7% |
| 2019 | $259337.00 | - |